NEW YORK (GenomeWeb News) — Caliper Life Sciences today said first-quarter revenues increased 27 percent as R&D spending grew 29 percent to contribute to a 120-percent surge in net losses.
 
Separately today, the company said it has licensed microfluidics IP from Monogram.
 
Total receipts for the three months ended March 31 increased to $28.4 million from $22.3 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.